Patent application number | Description | Published |
20080275025 | Substituted Lactams and Their Use as Anti-Cancer Agents - This invention relates to certain substituted lactam compounds, particularly caprolactam compounds, which are useful for the treatment of cancer. | 11-06-2008 |
20080319045 | Combination of Histone Deacetylase Inhibitors and Radiation - This invention relates to organic compounds of formula (I): | 12-25-2008 |
20090098137 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - A combination of an mTOR inhibitor compound with one or more pharmaceutically active agents, for simultaneous, concurrent, separate or sequential use for preventing or treating a proliferative disease. | 04-16-2009 |
20090099103 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - The invention relates to a combination comprising an Erb-B and VEGF receptor inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 04-16-2009 |
20100028338 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - A combination therapy for treating patients suffering from proliferative diseases or diseases associated with persistent angiogenesis is disclosed. The patient is treated with a camptothecin derivative and one or more chemotherapeutic agents selected from a microtubule active agent; an alkylating agent; an anti-neoplastic anti-metabolite; a platin compound; a topoisomerase II inhibitor; a VEGF inhibitor; a tyrosine kinase inhibitor; an EGFR kinase inhibitor; an mTOR kinase inhibitor; an insulin-like growth factor I inhibitor; a Raf kinase inhibitor; a monoclonal antibody; a proteasome inhibitor; a HDAC inhibitor; and ionizing radiation. | 02-04-2010 |
20100311805 | COMBINATION OF HISTONE DEACETYLASE INHIBITORS AND RADIATION - This invention relates to organic compounds of formula (I): | 12-09-2010 |
20110257206 | Combinations of Therapeutic Agents for Treating Cancer - The invention relates to a combination comprising a microtubule active agent; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 10-20-2011 |
20120129881 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - A combination of an mTOR inhibitor compound with one or more pharmaceutically active agents, for simultaneous, concurrent, separate or sequential use for preventing or treating a proliferative disease. | 05-24-2012 |
20120252811 | COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER - The invention relates to a combination comprising a Bcr-Abl, c-Kit and PDGF-R tyrosine kinase inhibitor; and one or more pharmaceutically active agents; pharmaceutical compositions comprising said combination; methods of treatment comprising said combination; processes for making said combination; and a commercial package comprising said combination. | 10-04-2012 |